Worth Attention Breast SBRT phase 2 Single-fraction GammaPod boost shows limited late toxicity in high-risk early breast cancer In 70 patients, a 7.5-Gy stereotactic tumor-bed boost before whole-breast RT produced 7% grade 2 fibrosis and no grade ≥3 late toxicity. RadOncToday · 7 Nov 2026 ·2 min read